General Information
Version
7.0
Revision date
2026-01-21
Product name
Proligestone Formulation
1.2.1 Relevant identified uses
Pharmaceutical
Icons in SDS
Company Information
company name
MSD
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@msd.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360D, H373
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
GHS Classification Carcinogenicity Category 2 Reproductive toxicity Category 1 Specific target organ toxicity - Category 2 (Adrenal gland, Ovary, Uterus (including cervix)) repeated exposure
Signal word
Danger
Hazard statements
H351 Suspected of causing cancer. H360D May damage the unborn child. H373 May cause damage to organs (Adrenal gland, Ovary, Uterus (including cervix)) through prolonged or repeated expo- sure.
Prevention
P201 Obtain special instructions before use. P260 Do not breathe mist or vapours. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Carcinogenicity : Category 2 Reproductive toxicity : Category 1 Specific target organ toxicity - : Category 2 (Adrenal gland, Ovary, Uterus (including cervix)) repeated exposure
